Navigation Links
Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
Date:8/31/2007

SAN DIEGO, Aug. 31 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced today that the company is scheduled to present at the NewsMakers in the Biotech Industry Conference on September 6, 2007 at 10:00 a.m. Eastern Time (7:00 a.m. Pacific Time) at the Millennium Broadway Hotel in New York City. Jack Lief, Arena's President and Chief Executive Officer, is scheduled to provide a corporate overview of the company and its clinical development and discovery programs.

A live audio webcast of the presentation will be available under the investor relations section of Arena's website at http://www.arenapharm.com. A replay of the presentation will be available for 30 days following the event. Please connect to Arena's website several minutes prior to the start of the webcast to ensure adequate time for any software download that may be necessary.

About Arena Pharmaceuticals

Arena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory, and metabolic diseases. Arena's most advanced product candidate, lorcaserin, is being investigated in a Phase 3 clinical trial program for the treatment of obesity. Arena's broad pipeline of novel compounds targeting G protein-coupled receptors, an important class of validated drug targets, includes compounds being evaluated independently and with its partners, Merck & Co., Inc. and Ortho-McNeil Pharmaceutical, Inc.

Arena Pharmaceuticals(R) and Arena(R) are registered service marks of the company. "APD" is an abbreviation for Arena Pharmaceuticals Develop
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Supply of Radiopharmaceuticals Hampered by Attacks
2. FDA approves Watson Pharmaceuticals Oxytrol patch
3. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
4. Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine
5. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
6. Top Pharmaceuticals Influence Doctors Prescriptions
7. More Study On Side Effects of ADHD Drug Needed: Shire Pharmaceuticals
8. Personalized Medicine and Innovative Pharmaceuticals
9. New lease of life for asthmatics by Accentia Biopharmaceuticals
10. Pravastatin Launched by Watson Pharmaceuticals
11. Tata Industries picks up stake in Indigene Pharmaceuticals

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... , WASHINGTON, Nov. 20 /PRNewswire-USNewswire...ng senators to modify health care reform legislati... regarding a health insurance individual coverage ...enforceable mandate will minimize adverse selectio...rules prescribed by the bill. ,, "The individua...
(Date:11/20/2009)... Senators and Congressmen in C... Over their Health Care Vote , ...Senators and congressmen running for re-election n...tical guru Charlie Cook, may come to regret voting...e bill, according to a breaking Zogby Internationa...
(Date:11/20/2009)... , ST. LOUIS, Nov. 20 /PRNewswire-FirstCall/...ounced that it will present at the Bank of America...December 2-3, 2009, at the Crowne Plaza Hotel Time...ent Wednesday, December 2nd at 8:30 a.m. Eastern T...cess a live, audio webcast of Centene,s presentati...
(Date:11/20/2009)..., LAS VEGAS, Nov. 20 ...ecutive Director of the Nevada Health Care Associa...HCA) commends and thanks Senate Majority Leader Ha... step closer toward our goal of protecting every N...ome care, and preserving the strength and viabilit...
(Date:11/20/2009)...g durations of exposure to formaldehyde used for e...ith an increased risk of death from myeloid leukem...mber 20 in the Journal of the National Cancer Ins...rtality from lymphohematopoietic malignancies and ...ral industry workers, all of whom may have worked ...
Breaking Medicine News(10 mins):Health News:Actuaries to Senate: Strengthen Individual Mandate 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3Health News:Funeral industry workers exposed to formaldehyde face higher risk of leukemia 2
... of medications, even if they are placebos, do bet...t adhere to any pattern, according to Canadian res...gs, researchers observe its effects on groups of p...cal trials. Researchers have always been bew...
...ain edible vaccine could be used against two of th...itis B//. Researchers have declared that it...ould be grown and processed in poorer countries wh...titute of Plant Physiology in Russia, in his resea...
...health bosses who have told staff to leave corpses...n a hospital bed for four days//, lashed out at th...egraph revelation that cash-strapped bosses are no...een left for eight hours last Wednesday because of...
...hopes dashed after National Institutes of Health p... ongoing studies of male //circumcision as a metho... a South African medical committee halted a circum...that the protective effect was so beneficial, beli...
...rgent wake-up call about their risk for heart dise...LBI) in the USA//, launched the Red Dress as the n...vate women to protect their heart health. Th...Olympus Fashion Week, to inaugurate the fourth col...
...ardiovascular disease 15 years prior to normal i...ian Booth, of the Institute of Clinical Evaluation...ay that a 40-year-old diabetic has the same chance... "People with diabetes certainly are at a hi...
Other Medicine News:Health News:Dead Body on Hospital Bed for Four Days 2Health News:Circumcision Studies to Continue Says Health Panel 2
(Date:11/19/2009)...e, Nov. 19 In response to an ever-...and illegal medicines, Operation Pangea II, involv...the World Health Organization,s International Medi...) to highlight the dangers of buying medicines onl...d in a series of arrests and the seizure of thousa...
(Date:11/19/2009)..., Nov. 19 Riverain Medical announc...leading Canadian medical imaging distributor Chris... and OnGuard Chest Xray CAD. The exclusive agreeme...s products to the Canadian market through Christie...,, SoftView Enhanced Chest Imaging increases th...
(Date:11/19/2009)... International Internet Week of Action ,, SILV... The U.S. Food and Drug Administration today compl..., called the International Internet Week of Action...g medical products. ,, (Logo: http://www.newsc...g the effort, the FDA,s Office of Criminal Investi...
Breaking Medicine Technology:International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2Riverain Medical Partners With The Christie Group In Canada To Offer SoftView Enhanced Chest Imaging and OnGuard Chest X-Ray CAD Technologies 2UPDATE: FDA Issues 22 Warning Letters to Web site Operators 2Lilly and New York City Mayor Michael R Bloomberg Announce Lilly Agrees to be First Tenant of East River Science Park 3B Issue Urgent Call for Health 4768 1Lilly and New York City Mayor Michael R Bloomberg Announce Lilly Agrees to be First Tenant of East River Science Park 3B Issue Urgent Call for Health 4768 2Lilly and New York City Mayor Michael R Bloomberg Announce Lilly Agrees to be First Tenant of East River Science Park 3B Issue Urgent Call for Health 4768 3Lilly and New York City Mayor Michael R Bloomberg Announce Lilly Agrees to be First Tenant of East River Science Park 3B Issue Urgent Call for Health 4768 4Lilly and New York City Mayor Michael R Bloomberg Announce Lilly Agrees to be First Tenant of East River Science Park 3B Issue Urgent Call for Health 4768 5my1HIE Fuels the Growth of E Prescribing in Michigan 52449 1my1HIE Fuels the Growth of E Prescribing in Michigan 52449 2my1HIE Fuels the Growth of E Prescribing in Michigan 52449 3my1HIE Fuels the Growth of E Prescribing in Michigan 52449 4my1HIE Fuels the Growth of E Prescribing in Michigan 52449 5my1HIE Fuels the Growth of E Prescribing in Michigan 52449 6Alexandria Real Estate Equities Inc Signs Biopharmaceutical Company Lilly as Anchor New York City Tenant at the Alexandria Center for Science and 13153 1Alexandria Real Estate Equities Inc Signs Biopharmaceutical Company Lilly as Anchor New York City Tenant at the Alexandria Center for Science and 13153 2Alexandria Real Estate Equities Inc Signs Biopharmaceutical Company Lilly as Anchor New York City Tenant at the Alexandria Center for Science and 13153 3Alexandria Real Estate Equities Inc Signs Biopharmaceutical Company Lilly as Anchor New York City Tenant at the Alexandria Center for Science and 13153 4
...l Published in CANCER: the Journal of the ...Jan. 22 Cell Therapeutics, Inc.,(CTI) (Nasdaq: C...e II,clinical study, published in the journal CANC...rapy (RIT) to chemotherapy for previously,untreate...n,s lymphoma,(NHL) was both well tolerated and eff...
... genetic study,has identified multiple genes linke...a debilitating autoimmune disease that affects an ...t the joints, kidneys, heart, lungs, brain and blo...ple. Women are nine times more,likely than men to ...,diagnose., In 2005 the Alliance for Lupus Resear...
Other Medicine Technology:Phase II Study of Zevalin(R) Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 89 Percent Three-Year Progression Free Survival in Patients with Previously Untreated Non-Follicular Indolent 2Phase II Study of Zevalin(R) Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 89 Percent Three-Year Progression Free Survival in Patients with Previously Untreated Non-Follicular Indolent 3Phase II Study of Zevalin(R) Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 89 Percent Three-Year Progression Free Survival in Patients with Previously Untreated Non-Follicular Indolent 4Phase II Study of Zevalin(R) Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 89 Percent Three-Year Progression Free Survival in Patients with Previously Untreated Non-Follicular Indolent 5Steps Toward Stopping Autoimmune Disease: International Consortium Identifies Genes Linked to Lupus 2Steps Toward Stopping Autoimmune Disease: International Consortium Identifies Genes Linked to Lupus 3
...cy Ultrasound system is the most advanced and vers...able. The HF35-50 allows users to perform high fre...gment with 35MHz or 50MHz probes or high resolutio...d B-probe. , ,The Macintosh computer provides ...
...ast and simple operation. Tone-assisted measuremen...& measurements are recorded. The AL-100 takes up t... AL-100 measures axial lengths from 15-40mm with a...e modes include Normal, Aphakic, Pseudophakic and ...
AL-3000 A-Scan Unit
...le, digital A-scan system which provides easy-to-u...gh frequency, low noise probe and fast precise alg...cation of the probe along the visual axis. The Pac...f 5 different user profiles, 5 different examinati...
Medicine Products: